IS7548A - Aðfer til þess að vernda innþekju- og útþekjufrumur meðan á efnameðferð stendur - Google Patents

Aðfer til þess að vernda innþekju- og útþekjufrumur meðan á efnameðferð stendur

Info

Publication number
IS7548A
IS7548A IS7548A IS7548A IS7548A IS 7548 A IS7548 A IS 7548A IS 7548 A IS7548 A IS 7548A IS 7548 A IS7548 A IS 7548A IS 7548 A IS7548 A IS 7548A
Authority
IS
Iceland
Prior art keywords
epithelial
methods
protecting
cells during
during chemotherapy
Prior art date
Application number
IS7548A
Other languages
English (en)
Inventor
Eissner Guenther
Holler Ernst
Original Assignee
Klinikum Der Universitaet Regensburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klinikum Der Universitaet Regensburg filed Critical Klinikum Der Universitaet Regensburg
Publication of IS7548A publication Critical patent/IS7548A/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
IS7548A 2002-05-31 2004-11-24 Aðfer til þess að vernda innþekju- og útþekjufrumur meðan á efnameðferð stendur IS7548A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38411402P 2002-05-31 2002-05-31
US38743802P 2002-06-11 2002-06-11
PCT/EP2003/005753 WO2003101468A1 (en) 2002-05-31 2003-06-02 Method for the protection of endothelial and epithelial cells during chemotherapy

Publications (1)

Publication Number Publication Date
IS7548A true IS7548A (is) 2004-11-24

Family

ID=29715309

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7548A IS7548A (is) 2002-05-31 2004-11-24 Aðfer til þess að vernda innþekju- og útþekjufrumur meðan á efnameðferð stendur

Country Status (16)

Country Link
EP (1) EP1509235A1 (is)
JP (1) JP2005527636A (is)
CN (1) CN1304011C (is)
AU (1) AU2003238189A1 (is)
CA (1) CA2487171A1 (is)
EA (1) EA008213B1 (is)
HR (1) HRP20041213A2 (is)
IL (1) IL165353A0 (is)
IS (1) IS7548A (is)
MX (1) MXPA04011941A (is)
NO (1) NO20045655L (is)
NZ (1) NZ536864A (is)
PL (1) PL374402A1 (is)
RS (1) RS102504A (is)
UA (1) UA83628C2 (is)
WO (1) WO2003101468A1 (is)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20031714A1 (it) * 2003-09-05 2005-03-06 Gentium Spa Formazioni ad azione antitumorale.
DK2637672T3 (en) 2010-11-12 2018-10-22 Gentium S R L DEFIBROTID FOR USE IN PROPHYLAXY AND / OR TREATMENT OF GRAPHIC VERSUS HOST DISEASE (GVHD)
RU2627177C2 (ru) 2012-06-22 2017-08-03 Джентиум С.Р.Л. Способ определения биологической активности дефибротида, основанный на применении эуглобулина
EP3026122A1 (en) 2014-11-27 2016-06-01 Gentium S.p.A. Cellular-based method for determining the potency of defibrotide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998048843A1 (en) * 1997-04-28 1998-11-05 Arsinur Burcoglu Method of treating hiv infection and related secondary infections thereof

Also Published As

Publication number Publication date
NZ536864A (en) 2008-08-29
IL165353A0 (en) 2006-01-15
AU2003238189A1 (en) 2003-12-19
NO20045655L (no) 2004-12-27
JP2005527636A (ja) 2005-09-15
PL374402A1 (en) 2005-10-17
WO2003101468A1 (en) 2003-12-11
EA200401448A1 (ru) 2005-06-30
CN1655801A (zh) 2005-08-17
UA83628C2 (ru) 2008-08-11
EP1509235A1 (en) 2005-03-02
CA2487171A1 (en) 2003-12-11
HRP20041213A2 (en) 2006-04-30
EA008213B1 (ru) 2007-04-27
MXPA04011941A (es) 2005-07-26
RS102504A (en) 2006-12-15
CN1304011C (zh) 2007-03-14

Similar Documents

Publication Publication Date Title
DE60330151D1 (de) Brennstoffzellensystem
DE10324396A8 (de) Brennstoffzelle
DE60316596D1 (de) Brennstoffzellensystem
NO20032220D0 (no) Löfteverktöy II og fremgangsmåte for anvendelse av samme
DE60326112D1 (de) Brennstoffzellensystem
IS2283B (is) Lekaskorða fyrir raflausnarker
NO20031285L (no) Isolasjons-omlöps-overgangsskjöt
DE60331474D1 (de) Brennstoffzellensystem
NO20032504L (no) Tetningsblanding
DE602004016054D1 (de) Brennstoffzellensystem
DE60329024D1 (de) Brennstoffzelle
DE502004011730D1 (de) Brennstoffzellensystem
DE60207518D1 (de) Dämpfungseinrichtung
DE50303161D1 (de) Zentrierspanner
DE60303345D1 (de) Brennstoffzelle
DK1768691T3 (da) Aequorinholdige præparater og fremgangsmåder til anvendelse af samme
DE60321289D1 (de) Brennstoffzellensystem
DE60323022D1 (de) Brennstoffzelle
DE60312367D1 (de) Brennstoffzellensystem
DE502004008433D1 (de) Wägezelle
IS7548A (is) Aðfer til þess að vernda innþekju- og útþekjufrumur meðan á efnameðferð stendur
DE60314807D1 (de) Dichtungsvorrichtung
DE60329145D1 (de) Dichtungsvorrichtung
FR2834557B1 (fr) Station spatiale oceanique
DE60333617D1 (de) Mobilstation